Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
STRONG PETRO (00852) released its mid-term performance for 2025, with a net loss attributable to shareholders of 63.981 million Hong Kong dollars, a year-on-year increase of 631.2%.
MMG (01208) is continuing to progress the construction engineering of the Khoemacau expansion project located in the Khoemacau mining area.
Ganfeng Lithium Group (01772) completes the redemption of the first tranche of the 2025 Technology Innovation Bonds (Merger and Acquisition).
STRONG PETRO (00852) released its mid-term performance for 2025, with a net loss attributable to shareholders of 63.981 million Hong Kong dollars, a year-on-year increase of 631.2%.
MMG (01208) is continuing to progress the construction engineering of the Khoemacau expansion project located in the Khoemacau mining area.
Ganfeng Lithium Group (01772) completes the redemption of the first tranche of the 2025 Technology Innovation Bonds (Merger and Acquisition).
RECOMMEND
